Decade, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-21.
Decade, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 21, 2025. The filing reports $8M sold. Its industry group is Biotechnology. It names Devin Scannell (Executive Officer, Director, Promoter), Brian Naughton (Executive Officer, Director), Elliot Hershberg (Director) (SEC Form D, August 21, 2025).
Is this your company?
Sell to companies like Decade, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Decade, Inc.
Free to see. No signup.
More on the people and the money behind Decade, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in August 2025, largest first.
Get an email when Decade, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Decade, Inc. raises, hires or launches. No email unless you switch it on.
Watch Decade, Inc. →Get the full cited report on Decade, Inc.
What the filing shows about Decade, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Decade, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Decade, Inc.'s address as 800 W El Camino Real, Suite 180-47, Mountain View, CA 94040.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Decade, Inc. is a registered filer with the SEC (CIK 2082045) and has filed since 2025-08-21. 1 filing is on record, the latest on 2025-08-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Decade, Inc.'s Form D of 2025-08-21 names Devin Scannell, Brian Naughton and Elliot Hershberg as its officers, directors or promoters.
Its new offerings report $8M sold across 1 offering, as its own filings state.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Decade is an Applied AI Lab rethinking cancer from first principles.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Devin Scannell is named as Executive Officer and Director and Promoter on the Form D that Decade, Inc. filed with the SEC on 21 August 2025, one of 3 people that filing names.
Brian Naughton is named as Executive Officer and Director on the Form D that Decade, Inc. filed with the SEC on 21 August 2025, one of 3 people that filing names.
Elliot Hershberg is named as Director on the Form D that Decade, Inc. filed with the SEC on 21 August 2025, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2025-08-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Decade, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Decade, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Decade, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Decade, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Decade, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (decade.bio).
Each opens in a new tab, filled in for Decade, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/decade-inc-form-d-25000001